Intellectual Property - June 17, 2013
Human genes can’t be patented
On June 13, the US Supreme Court ruled unanimously that natural human genes cannot be patented. Human genes may not be patented, but artificially copied DNA however can be claimed as intellectual property, according to the decision. The ruling concerns a challenge to patents held by biotechnology company, Myriad Genetics Inc., on two genes that […]
New Market - June 15, 2013
To the East
The Chinese market is without doubt one that is highly sought-after by many companies seeking to expand their business. Before you enter this land of opportunities, here are some dos and don’ts to ponder. Since initiating market reforms in 1978, China has shifted from a centrally planned to a market based economy and has experienced […]
Acquisition - June 11, 2013
AstraZeneca buys Pearl Therapeutics for $1.15 billion
On June 10, AstraZeneca announced the acquisition of California-based Pearl Therapeutics to strengthen the company’s respiratory portfolio. Pearl Therapeutics is a privately held company focused on the development of inhaled small-molecule therapeutics for respiratory disease. The acquisition will according to the press release give AstraZeneca access to a potential new treatment for chronic obstructive pulmonary […]
MedTech Business - June 11, 2013
Ortivus wins large procurement
Swedish Ortivus has been pointed out as a supplier of medical records in a large European procurement involving several ambulance operations. According to the press release, the deal is of a significant value for the Ortivus business. The company states that no further information can be given at the moment, but will publish a press […]
Clinical Trials - June 10, 2013
Call for greater transparency in clinical trials
Recently, members of the European Parliament’s environment, health and food safety committee voted for greater transparency in the European Commission’s proposal to revise EU rules on clinical trials. Draft EU rules on clinical trials of new medicines were endorsed by the Public Health Committee on Wednesday May 29 2013. A regulation designed to encourage research […]
Agreement - June 10, 2013
Turku Science Park in new agreement
Turku Science Park has signed a new agreement with Akron Development Corporation to promote Finnish and American biotech. The Memorandum of Understanding and Cooperation, signed during a visit of Finnish delegation in Akron, is aimed at enhancing Akron Development Corporation and Turku Science Park’s respective contributions in the biomedical sector internationally. The agreement will open […]
